Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry

被引:82
作者
Tiller, Heidi [1 ]
Kamphuis, Marije M. [2 ]
Flodmark, Olof [3 ]
Papadogiannakis, Nikos [4 ]
David, Anna L. [5 ]
Sainio, Susanna [6 ]
Koskinen, Sinikka [6 ]
Javela, Kaija [6 ]
Wikman, Agneta Taune [7 ]
Kekomaki, Riitta [6 ]
Kanhai, Humphrey H. H. [2 ]
Oepkes, Dick [2 ]
Husebekk, Anne [8 ]
Westgren, Magnus [9 ]
机构
[1] Univ Hosp North Norway, Dept Obstet & Gynaecol, Tromso, Norway
[2] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands
[3] Karolinska Univ Sjukhuset, Neuroradiol Kliniken, Stockholm, Sweden
[4] Karolinska Inst, Dept Lab Med, Div Pathol, Sect Perinatal Pathol, Stockholm, Sweden
[5] UCL, Inst Womens Hlth, London, England
[6] Finnish Red Cross Blood Serv, Helsinki, Finland
[7] Karolinska Univ Hosp, Stockholm, Sweden
[8] Univ Tromso, Inst Med Biol, Tromso, Norway
[9] Karolinska Inst, Div Clin Sci Intervent & Technol, Dept Obstet & Gynaecol, Stockholm, Sweden
关键词
D O I
10.1136/bmjopen-2012-002490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To characterise pregnancies where the fetus or neonate was diagnosed with fetal and neonatal alloimmune thrombocytopenia (FNAIT) and suffered from intracranial haemorrhage (ICH), with special focus on time of bleeding onset. Design: Observational cohort study of all recorded cases of ICH caused by FNAIT from the international No IntraCranial Haemorrhage (NOICH) registry during the period 2001-2010. Setting: 13 tertiary referral centres from nine countries across the world. Participants: 37 mothers and 43 children of FNAIT pregnancies complicated by fetal or neonatal ICH identified from the NOICH registry was included if FNAIT diagnosis and ICH was confirmed. Primary and secondary outcome measures: Gestational age at onset of ICH, type of ICH and clinical outcome of ICH were the primary outcome measures. General maternal and neonatal characteristics of pregnancies complicated by fetal/neonatal ICH were secondary outcome measures. Results: From a total of 592 FNAIT cases in the registry, 43 confirmed cases of ICH due to FNAIT were included in the study. The majority of bleedings (23/43, 54%) occurred before 28 gestational weeks and often affected the first born child (27/43, 63%). One-third (35%) of the children died within 4 days after delivery. 23 (53%) children survived with severe neurological disabilities and only 5 (12%) were alive and well at time of discharge. Antenatal treatment was not given in most (91%) cases of fetal/neonatal ICH. Conclusions: ICH caused by FNAIT often occurs during second trimester and the clinical outcome is poor. In order to prevent ICH caused by FNAIT, at-risk pregnancies must be identified and prevention and/or interventions should start early in the second trimester.
引用
收藏
页数:8
相关论文
共 18 条
[1]  
Bax M, 2012, JAMA-J AM MED ASSOC, V296, P1602
[2]   Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus [J].
Bussel, James B. ;
Berkowitz, Richard L. ;
Hung, Crystal ;
Kolb, E. Anders ;
Wissert, Megan ;
Primiani, Andrea ;
Tsaur, Felicia W. ;
MacFarland, Janice G. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 203 (02) :135.e1-135.e14
[3]   NEURODEVELOPMENTAL OUTCOME OF TERM INFANTS WITH INTRAVENTRICULAR HEMORRHAGE [J].
JOCELYN, LJ ;
CASIRO, OG .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (02) :194-197
[4]   Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review [J].
Kamphuis, M. M. ;
Paridaans, N. ;
Porcelijn, L. ;
De Haas, M. ;
van der Schoot, C. E. ;
Brand, A. ;
Bonsel, G. J. ;
Oepkes, D. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (11) :1335-1343
[5]   Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions [J].
Kamphuis, Marije M. ;
Oepkes, Dick .
PRENATAL DIAGNOSIS, 2011, 31 (07) :712-719
[6]   Management of alloimmune thrombocytopenia [J].
Kanhai, H. H. H. ;
Porcelijn, L. ;
Engelfriet, C. P. ;
Reesink, H. W. ;
Panzer, S. ;
Ulm, B. ;
Goldman, M. ;
Bonacossa, I. ;
Richard, L. ;
David, M. ;
Taaning, E. ;
Hedegaard, M. ;
Kaplan, C. ;
Kiefel, V. ;
Meyer, O. ;
Salama, A. ;
Morelati, F. ;
Greppi, N. ;
Marconi, M. ;
Tassis, B. ;
Tsuno, N. H. ;
Takahashi, K. ;
Oepkes, D. ;
Porcelijn, L. ;
Kanhai, H. ;
Osnes, L. T. N. ;
Husebekk, A. ;
Killie, M. K. ;
Kjeldsen-Kragh, J. ;
Zupanska, B. ;
Muniz-Diaz, E. ;
Nogues, N. ;
Parra, J. ;
Urbaniak, S. J. ;
Cameron, A. .
VOX SANGUINIS, 2007, 93 (04) :370-385
[7]  
KIEFEL V, 1987, BLOOD, V70, P1722
[8]   A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia [J].
Kjeldsen-Kragh, Jens ;
Killie, Mette Kjaer ;
Tomter, Geir ;
Golebiowska, Elzbieta ;
Randen, Ingrid ;
Hauge, Reidun ;
Aune, Berit ;
Oian, Pal ;
Dahl, Lauritz B. ;
Pirhonen, Jouko ;
Lindeman, Rolf ;
Husby, Henrik ;
Haugen, Guttorm ;
Gronn, Morten ;
Skogen, Bjorn ;
Husebekk, Anne .
BLOOD, 2007, 110 (03) :833-839
[9]   Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia [J].
Kjeldsen-Kragh, Jens ;
Ni, Heyu ;
Skogen, Bjorn .
CURRENT OPINION IN HEMATOLOGY, 2012, 19 (06) :469-474
[10]  
Mao CY, 1999, J TROP PEDIATRICS, V45, P237, DOI 10.1093/tropej/45.4.237